Results 231 to 240 of about 838,521 (380)

Physician assistant for gynecology - exploring awareness and acceptance in Germany. [PDF]

BMC Health Serv Res
Andres S, Hancke K.
europepmc   +1 more source

Can A Catholic Be An Obstetrician-Gynecologist? [PDF]

, 1996
Hilgers, Thomas W.
core   +1 more source

Lactylation in cancer biology: Unlocking new avenues for research and therapy

Cancer Communications, EarlyView.
Abstract Lactylation, a newly identified post‐translational modification, plays a multifaceted role in cancer biology by integrating epigenetic and non‐epigenetic mechanisms. This review summarizes the latest research progress on lactylation, including its functions in epigenetic regulation and its broader impact on cellular processes.
Xiaoyu Hou, Zhenya Hong, Huimin Zeng, Changyi Zhang, Peng Zhang, Ding Ma, Zhiqiang Han   +6 more
wiley   +1 more source

Correction: A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway. [PDF]

Front Oncol
Jiao Y, Xiang Y.
europepmc   +1 more source

Abortion training in US obstetrics and gynecology residency programs

American Journal of Obstetrics and Gynecology, 2018
J. Steinauer, J. Turk, Tali S. Pomerantz, K. Simonson, L. Learman, U. Landy   +5 more
semanticscholar   +1 more source

Comparative Analysis of Septin Modifiers, Forchlorfenuron and UR214‐9, on Mitochondrial Fragmentation and Lytic Cell Death

Cytoskeleton, EarlyView.
ABSTRACT Septins are conserved GTP‐binding proteins that play key roles in cell division, mitochondrial dynamics and immune responses. Despite their importance to human health, pharmacological compounds to modify septins remain limited. Forchlorfenuron (FCF) was the first small molecule identified to modify septins, disrupting their organisation and ...
Dominik Brokatzky, Rajdeep Das, Hannah Painter, Rakesh K. Singh, Serge Mostowy   +4 more
wiley   +1 more source

The use of mass spectrometry in obstetric and gynecology

Open Chemistry, 2013
Ilia Gheorghe, Crasmareanu Eleonora, Pascut Dan, Darabanti Laura, Simulescu Vasile   +4 more
doaj   +1 more source

Cure of Recurrent Ovarian Cancer: A Multicenter Retrospective Study. [PDF]

Cancers (Basel)
Sumitomo M, Kotani Y, Murakami K, Abiko K, Sakai K, Otani T, Ueda A, Ukita M, Taga A, Emoto I, Sekiyama K, Okudate M, Matsubara M, Yamanishi Y, Nishio K, Mandai M, Matsumura N.   +16 more
europepmc   +1 more source

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

Clinical Pharmacology &Therapeutics, EarlyView.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum, Élise Dumas, Joe‐Elie Salem, Stéphane Ederhy, Anne‐Sophie Hamy, Lise Lecointre, Enora Laas, Fabien Reyal, Fabrice Lecuru, Cherif Akladios, Paul Gougis   +10 more
wiley   +1 more source

Tubal pregnancy delivered at term of a live birth: a case report. [PDF]

J Surg Case Rep
Onuh SA, Aliyu FE, Ejawemokie B, Umar M, Mohammed AHM, Weizsacker K.   +5 more
europepmc   +1 more source